Farmacia Hospitalaria y Farmacogenómica

Collado-Borrell, R; Escudero-Vilaplana, V; Ribed, A; Gonzalez-Anleo, C; Martin-Conde, M; Romero-Jimenez, R; Iglesias-Peinado, I; Herranz-Alonso, A; Sanjurjo-Saez, M.

Effect of a Mobile App for the Pharmacotherapeutic Follow-Up of Patients With Cancer on Their Health Outcomes: Quasi-Experimental Study

JMIR mHealth and uHealth. 2020; 8(10): Nº de citas: 15 [doi:10.2196/20480]

Salvador-Martin, S; Bossacoma, F; Pujol-Muncunill, G; Navas-Lopez, VM; Gallego-Fernandez, C; Viada, J; Muñoz-Codoceo R; Magallares, L; Martinez-Ojinaga, E; Moreno-Alvarez, A; Solar-Boga, A; Segarra, O; Clemente, S; Rodriguez-Martinez, A; Alvarez-Vayo, C; Loverdos, I; Merino-Bohorquez, V; Balboa-Vega, MJ; Blanca-Garcia, JA; Fobelo, MJ; Millan-Jimenez, A; Garcia-Romero, R; Sanchez, C; Tolin, M; Caldas RG; Eizaguirre, FJ; Sanchez-Hernandez, JG; Torres-Peral, R; Aznal, E; Garcia-Gonzalez, X; Sanjurjo-Saez, M; Lopez-Fernandez, LA.

Genetic Predictors of Long-term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 2020; 71(4): 508-515 Nº de citas: 15 [doi:10.1097/MPG.0000000000002840]

Escudero-Vilaplana, V; Calles, A; Collado-Borrell, R; Marzal-Alfaro, MB; Polanco, C; Garrido, C; Suarez, J; Ortiz, A; Appierto, M; Comellas, M; Lizan, L.

Standardizing Health Outcomes for Lung Cancer. Adaptation of the International Consortium for Health Outcomes Measurement Set to the Spanish Setting

Frontiers in Oncology. 2020; 10: Nº de citas: 9 [doi:10.3389/fonc.2020.01645]

Marzal-Alfaro, M; Rodriguez-Gonzalez, CG; Escudero-Vilaplana, V; Revuelta-Herrero, JL; Gonzalez-Haba, E; Ibanez-Garcia, S; Iglesias-Peinado, I; Herranz-Alonso, A; Saez, MS.

Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients' safety

Health Informatics Journal. 2020; 26(3): 1995-2010 Nº de citas: 4 [doi:10.1177/1460458219895434]

Marquinez-Alonso, I; Escudero-Vilaplana, V; Osorio, S; Rodriguez-Gonzalez, CG; Gonzalez-Haba, E; Sanjurjo-Saez, M.

Evaluation of the use, effectiveness and safety of tyrosine kinase inhibitors in chronic myelogenous leukaemia in a general university hospital

European Journal of Hospital Pharmacy-Science and Practice. 2020; 27(5): 299-301 Nº de citas: 2 [doi:10.1136/ejhpharm-2017-001378]

Gonzalez-Haba-Pena, E; Garrido-Siles, M; Martinez-Bautista, MJ; Burgos-San Jose, A; Aldaz-Pastor, A; Mangues-Bafalluy, I; Spanish Soc Hosp Pharmacists.

Observational study of clinical toxicity with different formulations of docetaxel in breast cancer patients

FARMACIA HOSPITALARIA. 2020; 44(5): 192-197 Nº de citas: 2 [doi:10.7399/fh.11402]

Collado-Borrell, R; Escudero-Vilaplana, V; Ribed, A; Jimenez, RR; Peinado, II; Herranz-Alonso, A; Sanjurjo-Saez, M.

Novel mobile application for direct communication between pharmacists and patients treated with oral antineoplastic agents

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. 2020; 77(17): 1393-1402 Nº de citas: 4 [doi:10.1093/ajhp/zxaa144]

Collado-Borrell, R; Escudero-Vilaplana, V; Villanueva-Bueno, C; Herranz-Alonso, A; Sanjurjo-Saez, M.

Features and Functionalities of Smartphone Apps Related to COVID-19: Systematic Search in App Stores and Content Analysis

JOURNAL OF MEDICAL INTERNET RESEARCH. 2020; 22(8): Nº de citas: 67 [doi:10.2196/20334]

Escudero-Vilaplana, V; Collado-Borrell, R; Hoyo-Munoz, A; Gimenez-Manzorro, A; Calles, A; Osorio, S; Herranz-Alonso, A; Sanjurjo-Saez, M.

Potential drug interactions between targeted oral antineoplastic agents and concomitant medication in clinical practice

Expert Opinion On Drug Safety. 2020; 19(8): 1041-1048 Nº de citas: 12 [doi:10.1080/14740338.2020.1781089]

Garcia, M; Lopez-Fernandez, L; Minguez, P; Moron-Lopez, S; Restrepo, C; Navarrete-Munoz, MA; Lopez-Bernaldo, JC; Benguria, A; Garcia, MI; Cabello, A; Fernandez-Guerrero, M; De la Hera, FJ; Estrada, V; Barros, C; Martinez-Picado, J; Gorgolas, M; Benito, JM; Rallon, N.

Transcriptional signature of resting-memory CD4 T cells differentiates spontaneous from treatment-induced HIV control

JOURNAL OF MOLECULAR MEDICINE-JMM. 2020; 98(8): 1093-1105 Nº de citas: 7 [doi:10.1007/s00109-020-01930-x]

Amor-Garcia, MA; Collado-Borrell, R; Escudero-Vilaplana, V; Melgarejo-Ortuno, A; Herranz-Alonso, A; Arija, JAA; Sanjurjo-Saez, M.

Assessing Apps for Patients with Genitourinary Tumors Using the Mobile Application Rating Scale (MARS): Systematic Search in App Stores and Content Analysis

JMIR mHealth and uHealth. 2020; 8(7): Nº de citas: 40 [doi:10.2196/17609]

Ribed, A; Monje, B; Garcia-Gonzalez, X; Sanchez-Somolinos, M; Sanz-Ruiz, P; Rodriguez-Gonzalez, CG; Sanjurjo-Saez, M.

Improving surgical antibiotic prophylaxis adherence and reducing hospital readmissions: a bundle of interventions including health information technologies

European Journal of Hospital Pharmacy-Science and Practice. 2020; 27(4): 237-242 Nº de citas: 9 [doi:10.1136/ejhpharm-2018-001666]

Garcia-Gonzalez, X; Kaczmarczyk, B; Abarca-Zabalia, J; Thomas, F; Garcia-Alfonso, P; Robles, L; Pachon, V; Vaz, A; Salvador-Martin, S; Sanjurjo-Saez, M; Lopez-Fernandez, LA.

New DPYD variants causing DPD deficiency in patients treated with fluoropyrimidine

CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2020; 86(1): 45-54 Nº de citas: 17 [doi:10.1007/s00280-020-04093-1]

Tortajada-Goitia, B; Morillo-Verdugo, R; Margusino-Framinan, L; Marcos, JA; Fernandez-Llamazares, CM.

Survey on the situation of telepharmacy as applied to the outpatient care in hospital pharmacy departments in Spain during the COVID-19 pandemic

FARMACIA HOSPITALARIA. 2020; 44(4): 135-140 Nº de citas: 43 [doi:10.7399/fh.11527]

Diaz-Carrasco, MS; Gonzalez-Haba, E; Garcia-Soler, JI; Espuny-Miro, A.

Predictive biomarkers of response to immune checkpoint inhibitors

FARMACIA HOSPITALARIA. 2020; 44(4): 141-148 Nº de citas: 3 [doi:10.7399/fh.11328]

Rodriguez-Gonzalez, CG; Chamorro-de-Vega, E; Ortega-Navarro, C; Alonso, R; Herranz-Alonso, A; Sanjurjo-Saez, M.

Effectiveness, Safety, and Costs of Dolutegravir/Abacavir/Lamivudine Single-Tablet Regimen in a Real-Life Cohort of HIV-1 Adult Infected Patients

ANNALS OF PHARMACOTHERAPY. 2020; 54(7): 633-643 Nº de citas: 10 [doi:10.1177/1060028019896638]

Ortuno, AM; Jimenez, RMR; Navarro, CO; Flores, MF; Saez, MS.

Quality control of parenteral nutrition compounding: gravimetric and component verification control

Nutricion Hospitalaria. 2020; 37(4): 667-671 Nº de citas: 3 [doi:10.20960/nh.03037]

Fernandez-Cruz, A; Ortega, L; Garcia, G; Gallego, I; Alarez-Uria, A; Chamorro-de-Vega, E; Garcia-Lopez, JJ; Gonzalez-del-Val, R; Martin-Rabadan, P; Rodriguez, C; Pedro-Botet, ML; Martin, M; Bouza, E.

Etiology and Prognosis of Pneumonia in Patients with Solid Tumors: A Prospective Cohort of Hospitalized Cases

ONCOLOGIST. 2020; 25(5): 861-869 Nº de citas: 5 [doi:10.1634/theoncologist.2019-0031]